-+ 0.00%
-+ 0.00%
-+ 0.00%

The State Drug Administration recently passed a priority review and approval procedure to approve the listing of resicibizumab injections declared by Shanghai Huaotai Biopharmaceutical Co., Ltd. to treat generalized pustular psoriatic attacks in adults. The marketing of this variety provides new treatment options for relevant patients.

Zhitongcaijing·07/29/2026 09:41:12
Listen to the news
The State Drug Administration recently passed a priority review and approval procedure to approve the listing of resicibizumab injections declared by Shanghai Huaotai Biopharmaceutical Co., Ltd. to treat generalized pustular psoriatic attacks in adults. The marketing of this variety provides new treatment options for relevant patients.